Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Background of Heart Failure
Author(s): Raluca Ibănescu , Diana-Alexandra Mîțu , Iacob-Daniel Goje , et al Added: 1 year ago

Imaging & Diagnostics

Heart Failure
Cardiogenic Shock in Restrictive Cardiomyopathies
Author(s): Ossama K Abou Hassan , Ebere Chukwu , John Schmittner , et al Added: 8 months ago

Heart Failure
Added: 9 months ago Source:  Radcliffe CVRM
AUTHOR: Liam ONeillWhile elevated systolic blood pressure variability (SBPV) is a known risk factor for adverse health outcomes, new research published in the European Heart Journal suggests that the change in SBPV over time is also a critical prognostic indicator. The study found that an increase in visit-to-visit SBPV over a 10-year period was significantly associated with a higher risk of… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
Apelin/APJ and Incretin Therapy in Heart Failure
Author(s): Dominic Marcel Alfonso Added: 1 month ago

MI/ACS

Heart Failure
Medhi Eskandari
Job title: Consultant Cardiologist
Dr Mehdi Eskandari is an Australian-trained Consultant Cardiologist providing comprehensive adult cardiology care. At Qualitas in Melbourne, he sees patients with common cardiac presentations, including chest pain, breathlessness, palpitations, hypertension, arrhythmias and cardiovascular risk management, with a focus on accurate diagnosis and evidence-based, practical treatment plans.After… View more
ESC 24: FINE-HEART: Finerenone in HF & CKD
Author(s): Muthiah Vaduganathan Added: 1 year ago
ESC Congress 2024 — Finerenone improved outcomes in two trials in patients with CKD with T2D, and in patients with HFmrEF and HFpEF.Investigator, Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) joins us in London to discuss the findings from the FINE-HEART pooled analysis (Bayer).FINE-HEART is a pre-specified, exploratory pooled analysis combining data from three phase III clinical… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
HFSA 25: The ATTRibute-CM Trial
Author(s): Ahmad Masri Added: 6 months ago
HFSA 2025 - Post hoc analysis of ATTRibute-CM reveals significant reduction in cardiovascular mortality and death after 30 months of acoramidis in patients with ATTR-CM.Dr Ahmad Masri (Oregon Health & Science University, US) joins us to discuss a post hoc exploratory analysis from the ATTRibute-CM trial examining the timing and magnitude of cardiovascular outcome reductions with acoramidis in… View more

Heart Failure
Precision in Practice: Navigating Amyloidosis Diagnosis and Referral
Author(s): Margot K Davis , , , et al Added: 11 months ago
In this symposium, filmed at HFA 2025 (Belgrade, RS), moderator Dr Margot Davis (Vancouver, CA) is joined by Prof Fabian Knebel (Berlin, DE), Dr AleksandarAleksandrov (Berlin, DE) and Prof Olivier Lairez (Toulouse, FR) to unpack a recent, real-life patient referral. The faculty explore the challenges faced during the referral process and then evaluate the practical steps for making a confident… View more

Heart Failure
Aficamten Superior to Metoprolol in oHCM: MAPLE-HCM
Added: 1 month ago Source:  CFR Journal Radcliffe Cardiology
A prespecified, secondary analysis of the MAPLE-HCM trial has shown that aficamten monotherapy provides superior and rapid benefits across multiple domains of disease burden compared with metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).¹ Aficamten is a next-in-class cardiac myosin inhibitor (CMI) designed to reduce myocardial hypercontractility by decreasing… View more

Heart Failure
3 Trials That Will Change My Practice
Author(s): Muthiah Vaduganathan Added: 1 year ago
ESC 2024 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical School, US) for a concise and insightful summary of the hot-line and late-breaking data that is expected to have an impact on heart failure care.Trials covered in detail include:FINEARTS HFHELIOS-BRESHAPE-HF2Recorded on-site at ESC Congress 2024, London.Editors: Jordan Rance and Mirjam Boros… View more

Heart Failure